Company: AGIO
Filing Date: 2025-06-18
Form Type: 8-K
Source: 0001193125-25-142745
Chunk: 2

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-06-18
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01.      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit      Description of Exhibit                                                                                                                                                                                
                                                                                                                                                                                                                     
   Number                                                                                                                                                                                                            
     99.1      Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as amended (incorporated by reference to Appendix A of the registrant’s Definitive Proxy Statement on Schedule 14A (File No. 001-36014) fi...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                                                           

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           AGIOS PHARMACEUTICALS, INC.                               
  Date: June 18, 2025      By:                              /s/ Brian Goff           
                                                            Brian Goff               
                                                            Chief Executive Officer